Carlsbad, CA-based Life Technologies (NASDAQ:[[ticker:LIFE]]) said today that it plans to sell its stake in its mass spectrometry business to Danaher (NYSE:[[ticker:DHR]]) for $450 million in cash. Danaher, based in Washington, D.C., has also agreed to buy the company with which Life Technologies jointly owns the business, MDS Analytical Technologies, headquartered in Ontario, Canada. Life Technologies, a provider of tools for biological research, expects the transaction to close in the fourth quarter of this year.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
